Angela Vidal-Jordana
Overview
Explore the profile of Angela Vidal-Jordana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vidal-Jordana A, Ontaneda D
Neurology
. 2025 Mar;
104(7):e213416.
PMID: 40036710
No abstract available.
2.
Marrodan M, Sao Aviles A, Rio J, Cobo-Calvo A, Fernandez V, Pappolla A, et al.
Mult Scler
. 2025 Feb;
:13524585251316471.
PMID: 39925147
Background: Predicting treatment response and disease progression in multiple sclerosis (MS) is challenging. Treatment Response Scoring Systems (TRSS) are potentially useful, but their utility in patients receiving high-efficacy therapies and...
3.
Vilaseca A, Tintore M, Carbonell-Mirabent P, Rodriguez-Barranco M, Arevalo M, Arino H, et al.
Mult Scler
. 2025 Feb;
:13524585251314749.
PMID: 39907218
Background: It is essential to exclude alternative diagnoses to diagnose multiple sclerosis (MS). However, detailed descriptions of alternative diagnoses in patients with suspected MS presenting with clinically isolated syndrome (CIS)...
4.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, et al.
Neurology
. 2025 Feb;
104(4):e210305.
PMID: 39903901
Background And Objectives: Emerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is increasingly...
5.
Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Aviles A, Arrambide G, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200370.
PMID: 39879564
Background And Objectives: Invasive procedures may delay the diagnostic process in multiple sclerosis (MS). We investigated the added value of serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP),...
6.
Marti-Juan G, Sastre-Garriga J, Vidal-Jordana A, Llufriu S, Martinez-Heras E, Groppa S, et al.
Netw Neurosci
. 2024 Dec;
8(4):1545-1562.
PMID: 39735510
Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system. Structures affected in MS include the corpus callosum, connecting the hemispheres. Studies have shown that in mammalian...
7.
Mongay-Ochoa N, Pareto D, Alberich M, Carbonell-Mirabent P, Valsasina P, Margoni M, et al.
Neurology
. 2024 Dec;
104(1):e210136.
PMID: 39666921
Background And Objectives: In multiple sclerosis (MS), brain reserve serves as a protective factor against cognitive impairment. Previous research has suggested a structural counterpart in the spine-spinal cord reserve-seemed to...
8.
Brownlee W, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, et al.
Ann Neurol
. 2024 Nov;
97(3):571-582.
PMID: 39605172
Objective: The 2017 McDonald criteria continued the separation of diagnostic criteria for relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS) for historical, rather than biological, reasons. We aimed to...
9.
Carvajal R, Rodriguez-Acevedo B, Garcia-Vasco L, Zabalza A, Arino H, Bollo L, et al.
Mult Scler
. 2024 Nov;
30(14):1788-1801.
PMID: 39520297
Background: Organizing pneumonia (OP), an interstitial lung disease, has been observed in patients with inflammatory demyelinating diseases (IDDs) treated with anti-CD20, particularly after COVID-19, but data are limited. Aim: To...
10.
Rocca M, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N, et al.
Lancet Reg Health Eur
. 2024 Oct;
44:100978.
PMID: 39444702
In the majority of cases, multiple sclerosis (MS) is characterized by reversible episodes of neurological dysfunction, often followed by irreversible clinical disability. Accurate diagnostic criteria and prognostic markers are critical...